0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Advances in the Management of Acute Nonlymphocytic Leukemia

Peter H. Wiernik, MD
Arch Intern Med. 1976;136(12):1399-1403. doi:10.1001/archinte.1976.03630120049015.
Text Size: A A A
Published online

Ten years ago, less than one fourth of patients with acute nonlymphocytic leukemia (ANLL) (acute myelocytic, myelomonocytic erythroleukemia, and monocytic leukemia) achieved complete remission of their disease with conventional or experimental chemotherapy. Today, two thirds or more of patients with that disease will achieve complete remission and, perhaps more importantly, the median duration of complete remission has been substantially improved recently by a combined modality approach to maintenance therapy. The result of these advances is that median survival of all treated patients, and of patients who achieve complete remission in particular, has greatly improved.

Important improvements in supportive care, chemotherapy, and immunotherapy have together resulted in justifiable optimism for the control of ANLL in the foreseeable future.

SUPPORTIVE CARE 

Infection Prevention  Infection during induction therapy resulting from granulocytopenia secondary to the disease and/or its therapy has claimed the lives of more than 25% of patients with ANLL before an adequate

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();